IBDEI0Y5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16031,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,16031,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,16032,0)
 ;;=D57.1^^61^716^29
 ;;^UTILITY(U,$J,358.3,16032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16032,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,16032,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,16032,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,16033,0)
 ;;=D64.0^^61^716^22
 ;;^UTILITY(U,$J,358.3,16033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16033,1,3,0)
 ;;=3^Anemia,Sideroblastic,Hereditary
 ;;^UTILITY(U,$J,358.3,16033,1,4,0)
 ;;=4^D64.0
 ;;^UTILITY(U,$J,358.3,16033,2)
 ;;=^5002344
 ;;^UTILITY(U,$J,358.3,16034,0)
 ;;=D64.1^^61^716^23
 ;;^UTILITY(U,$J,358.3,16034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16034,1,3,0)
 ;;=3^Anemia,Sideroblastic,Secondary d/t Disease
 ;;^UTILITY(U,$J,358.3,16034,1,4,0)
 ;;=4^D64.1
 ;;^UTILITY(U,$J,358.3,16034,2)
 ;;=^5002345
 ;;^UTILITY(U,$J,358.3,16035,0)
 ;;=D64.2^^61^716^24
 ;;^UTILITY(U,$J,358.3,16035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16035,1,3,0)
 ;;=3^Anemia,Sideroblastic,Secondary d/t Drugs/Toxins
 ;;^UTILITY(U,$J,358.3,16035,1,4,0)
 ;;=4^D64.2
 ;;^UTILITY(U,$J,358.3,16035,2)
 ;;=^5002346
 ;;^UTILITY(U,$J,358.3,16036,0)
 ;;=D64.9^^61^716^25
 ;;^UTILITY(U,$J,358.3,16036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16036,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16036,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16036,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16037,0)
 ;;=C50.912^^61^717^11
 ;;^UTILITY(U,$J,358.3,16037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16037,1,3,0)
 ;;=3^Malig Neop Breast,Left,Unspec Site
 ;;^UTILITY(U,$J,358.3,16037,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,16037,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,16038,0)
 ;;=C50.911^^61^717^12
 ;;^UTILITY(U,$J,358.3,16038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16038,1,3,0)
 ;;=3^Malig Neop Breast,Right,Unspec Site
 ;;^UTILITY(U,$J,358.3,16038,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,16038,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,16039,0)
 ;;=D05.01^^61^717^10
 ;;^UTILITY(U,$J,358.3,16039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16039,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,16039,1,4,0)
 ;;=4^D05.01
 ;;^UTILITY(U,$J,358.3,16039,2)
 ;;=^5001927
 ;;^UTILITY(U,$J,358.3,16040,0)
 ;;=D05.02^^61^717^9
 ;;^UTILITY(U,$J,358.3,16040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16040,1,3,0)
 ;;=3^Lobular Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,16040,1,4,0)
 ;;=4^D05.02
 ;;^UTILITY(U,$J,358.3,16040,2)
 ;;=^5001928
 ;;^UTILITY(U,$J,358.3,16041,0)
 ;;=D05.92^^61^717^5
 ;;^UTILITY(U,$J,358.3,16041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16041,1,3,0)
 ;;=3^Carcinoma in Situ,Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16041,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,16041,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,16042,0)
 ;;=D05.91^^61^717^6
 ;;^UTILITY(U,$J,358.3,16042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16042,1,3,0)
 ;;=3^Carcinoma in Situ,Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,16042,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,16042,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,16043,0)
 ;;=D05.11^^61^717^8
 ;;^UTILITY(U,$J,358.3,16043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16043,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,16043,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,16043,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,16044,0)
 ;;=D05.12^^61^717^7
 ;;^UTILITY(U,$J,358.3,16044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16044,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
